600
Views
11
CrossRef citations to date
0
Altmetric
Review

A holistic model of low vision care for improving vision‐related quality of life

, BOptom (Hons) BSc, , PhD MScOptom GradCertOcTher BSc (Optom) FAAO, , MSpec (Ed) SenDisa BOccThy (Hons), , BOptom (Hons)/BSc, , MSpec (Ed) SenDisa BPsych, , PhD DVM MN RN & , PhD GradCertOcTher BOptom (Hons) FAAO show all
Pages 733-741 | Received 19 Sep 2019, Accepted 23 Jan 2020, Published online: 15 Apr 2021

REFERENCES

  • National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Population Health and Public Health Practice, Committee on Public Health Approaches to Reduce Vision Impairment and Promote Eye Health. Making Eye Health a Population Health Imperative: Vision for Tomorrow. Washington, DC: National Academies Press, 2016.
  • Lamoureux EL, Pallant JF, Pesudovs K et al. The effectiveness of low‐vision rehabilitation on participation in daily living and quality of life. Invest Ophthalmol Vis Sci 2007; 48: 1476–1482.
  • Wilkinson ME, Shahid KS. Low vision rehabilitation: an update. Saudi J Ophthalmol 2018; 32: 134–138.
  • Taylor HR, Keeffe JE, Vu HT et al. Vision loss in Australia. Med J Aust 2005; 182: 565–568.
  • O'connor P, Keeffe J. Focus on Low Vision. Melbourne: CERA, 2007. pp. 1–28.
  • World Health Organization. International Classification of Disease‐10. Geneva: World Health Organization, 2016.
  • Owsley C, Jackson GR, Cideciyan AV et al. Psychophysical evidence for rod vulnerability in age‐related macular degeneration. Invest Ophthalmol Vis Sci 2000; 41: 267–273.
  • Owsley C, Mcgwin G Jr, Clark ME et al. Delayed rod‐mediated dark adaptation is a functional biomarker for incident early age‐related macular degeneration. Ophthalmology 2016; 123: 344–351.
  • Higgins KE, Wood JM. Predicting components of closed road driving performance from vision tests. Optom Vis Sci 2005; 82: 647–656.
  • Sahli E, Idil A. A common approach to low vision: examination and rehabilitation of the patient with low vision. Turk J Ophthalmol 2019; 49: 89–98.
  • Coker MA, Huisingh CE, Mcgwin G Jr et al. Rehabilitation referral for patients with irreversible vision impairment seen in a public safety‐net eye clinic. JAMA Ophthalmol 2018; 136: 400–408.
  • Owsley C, Mcgwin G Jr, Lee PP et al. Characteristics of low‐vision rehabilitation services in the United States. Arch Ophthalmol 2009; 127: 681–689.
  • Bruce I, Walker EC, Mckennell AC. Blind and Partially Sighted Adults in Britain: the RNIB Survey. London: Royal National Institute for the Blind, 1991.
  • Leat SJ, Fryer A, Rumney NJ. Outcome of low vision aid provision: the effectiveness of a low vision clinic. Optom Vis Sci 1994; 71: 199–206.
  • Robbins HG. Low vision care for the over 80's. Aust J Optom 1981; 64: 243–251.
  • Kiely PM, Slater J. Optometry Australia entry‐level competency standards for optometry 2014. Clin Exp Optom 2015; 98: 65–89.
  • Bentley SA, Jackson AJ, Johnston AW et al. Advancing low vision services: a plan for Australian optometry. Clin Exp Optom 2014; 97: 214–220.
  • Chiang PP, O'connor PM, Le mesurier RT et al. A global survey of low vision service provision. Ophthalmic Epidemiol 2011; 18: 109–121.
  • Elam AR, Lee PP. High‐risk populations for vision loss and eye care underutilization: a review of the literature and ideas on moving forward. Surv Ophthalmol 2013; 58: 348–358.
  • Gillespie‐gallery H, Conway ML, Subramanian A. Are rehabilitation services for patients in UK eye clinics adequate? A survey of eye care professionals. Eye (Lond) 2012; 26: 1302–1309.
  • Adelsberger J, Bertolet A, Humphreys E et al. Bridging the gap: improving the efficacy of referrals from primary care optometrists to low vision specialists. In: American Academy of Optometry Annual Meeting; 2014: NECO; 2014.
  • Kaleem MA, West SK, Im LT et al. Referral to low vision services for glaucoma patients: referral patterns and characteristics of those who refer. J Glaucoma 2017; 26: e115–e120.
  • Lam N, Leat SJ. Barriers to accessing low‐vision care: the patient's perspective. Can J Ophthalmol 2013; 48: 458–462.
  • Overbury O, Wittich W. Barriers to low vision rehabilitation: the Montreal barriers study. Invest Ophthalmol Vis Sci 2011; 52: 8933–8938.
  • Bakkar MM, Alzghoul EA, Haddad MF. Clinical characteristics and causes of visual impairment in a low vision clinic in northern Jordan. Clin Ophthalmol 2018; 12: 631–637.
  • Tadic V, Cooper A, Cumberland P et al. Measuring the quality of life of visually impaired children: first stage psychometric evaluation of the novel VQoL_CYP instrument. PLoS One 2016; 11: e0146225.
  • Mlinac ME, Feng MC. Assessment of activities of daily living, self‐care, and independence. Arch Clin Neuropsychol 2016; 31: 506–516.
  • AOTA. Occupational Therapy Practice Framework: Domain and Process, Vol. 68, 3rd ed. North Bethesda, MD: AOTA, 2014. p. 48.
  • Millan‐calenti JC, Tubio J, Pita‐fernandez S et al. Prevalence of functional disability in activities of daily living (ADL), instrumental activities of daily living (IADL) and associated factors, as predictors of morbidity and mortality. Arch Gerontol Geriatr 2010; 50: 306–310.
  • Koberlein J, Beifus K, Schaffert C et al. The economic burden of visual impairment and blindness: a systematic review. BMJ Open 2013; 3: e003471.
  • Zheng DD, Christ SL, Lam BL et al. Increased mortality risk among the visually impaired: the roles of mental well‐being and preventive care practices. Invest Ophthalmol Vis Sci 2012; 53: 2685–2692.
  • Dev MK, Paudel N, Joshi ND et al. Psycho‐social impact of visual impairment on health‐related quality of life among nursing home residents. BMC Health Serv Res 2014; 14: 345.
  • Kempen GI, Ballemans J, Ranchor AV et al. The impact of low vision on activities of daily living, symptoms of depression, feelings of anxiety and social support in community‐living older adults seeking vision rehabilitation services. Qual Life Res 2012; 21: 1405–1411.
  • Owen CG, Rudnicka AR, Smeeth L et al. Is the NEI‐VFQ‐25 a useful tool in identifying visual impairment in an elderly population? BMC Ophthalmol 2006; 6: 24.
  • Mangione CM, Lee PP, Pitts J et al. Psychometric properties of the National Eye Institute visual function questionnaire (NEI‐VFQ). NEI‐VFQ field test investigators. Arch Ophthalmol 1998; 116: 1496–1504.
  • Ni W, Li X, Ao M et al. Using the real‐life vision test to assess the functional vision of age‐related cataract patients. Eye (Lond) 2012; 26: 1402–1411.
  • West SK, Rubin GS, Broman AT et al. How does visual impairment affect performance on tasks of everyday life? The SEE project. Salisbury eye evaluation. Arch Ophthalmol 2002; 120: 774–780.
  • Hee OK, Thng ZX, Zhu HY et al. Usage of glaucoma‐specific patient‐reported outcome measures (PROMs) in the Singapore context: a qualitative scoping exercise. BMC Ophthalmol 2018; 18: 197.
  • de Boer MR, Moll AC, de Vet HC et al. Psychometric properties of vision‐related quality of life questionnaires: a systematic review. Ophthalmic Physiol Opt 2004; 24: 257–273.
  • Massof RW, Rubin GS. Visual function assessment questionnaires. Surv Ophthalmol 2001; 45: 531–548.
  • Mangione CM, Phillips RS, Seddon JM et al. Development of the 'Activities of Daily Vision Scale'. A measure of visual functional status. Med Care 1992; 30: 1111–1126.
  • Khadka J, Pesudovs K, Mcalinden C et al. Reengineering the glaucoma quality of life‐15 questionnaire with rasch analysis. Invest Ophthalmol Vis Sci 2011; 52: 6971–6977.
  • Khadka J, Mcalinden C, Pesudovs K. Quality assessment of ophthalmic questionnaires: review and recommendations. Optom Vis Sci 2013; 90: 720–744.
  • Deverell L, Meyer D, Lau BT et al. Optimising technology to measure functional vision, mobility and service outcomes for people with low vision or blindness: protocol for a prospective cohort study in Australia and Malaysia. BMJ Open 2017; 7: e018140.
  • Tadic V, Rahi JS. One size doesn't fit all: time to revisit patient‐reported outcome measures (PROMs) in paediatric ophthalmology? Eye (Lond) 2017; 31: 511–518.
  • Tabrett DR, Latham K. Factors influencing self‐reported vision‐related activity limitation in the visually impaired. Invest Ophthalmol Vis Sci 2011; 52: 5293–5302.
  • Friedman SM, Munoz B, Rubin GS et al. Characteristics of discrepancies between self‐reported visual function and measured reading speed. Salisbury Eye Evaluation Project team. Invest Ophthalmol Vis Sci 1999; 40: 858–864.
  • Dean S, Mathers JM, Calvert M et al. "The patient is speaking": discovering the patient voice in ophthalmology. Br J Ophthalmol 2017; 101: 700–708.
  • Zhang X, Bullard KM, Cotch MF et al. Association between depression and functional vision loss in persons 20-years of age or older in the United States, NHANES 2005‐2008. JAMA Ophthalmol 2013; 131: 573–581.
  • Wahl HW. The psychological challenge of late‐life vision impairment: concepts, findings, and practical implications. J Ophthalmol 2013; 2013: 278135.
  • Hazel CA, Petre KL, Armstrong RA et al. Visual function and subjective quality of life compared in subjects with acquired macular disease. Invest Ophthalmol Vis Sci 2000; 41: 1309–1315.
  • Smith AB, Hanbury A, Retzler J. Item banking and computer‐adaptive testing in clinical trials: standing in sight of the PROMISed land. Contemp Clin Trials Commun 2019; 13: 100306.
  • Massof RW, Ahmadian L, Grover LL et al. The activity inventory: an adaptive visual function questionnaire. Optom Vis Sci 2007; 84: 763–774.
  • Bruijning J, van Nispen R, Verstraten P et al. A Dutch ICF version of the activity inventory: results from focus groups with visually impaired persons and experts. Ophthalmic Epidemiol 2010; 17: 366–377.
  • Aaronson NK. Quality of life: what is it? How should it be measured? Oncology (Williston Park) 1988; 2: 69–76, 64.
  • Rovner BW, Ganguli M. Depression and disability associated with impaired vision: the MoVies project. J Am Geriatr Soc 1998; 46: 617–619.
  • Cimarolli VR, Casten RJ, Rovner BW et al. Anxiety and depression in patients with advanced macular degeneration: current perspectives. Clin Ophthalmol 2016; 10: 55–63.
  • Centre for Eye Research Australia. Patient‐Reported Outcome Questionnaires. Melbourne: Centre for Eye Research Australia, 2014.
  • Mangione CM, Lee PP, Gutierrez PR et al. Development of the 25‐item National Eye Institute visual function questionnaire. Arch Ophthalmol 2001; 119: 1050–1058.
  • Wolffsohn JS, Cochrane AL. Design of the low vision quality‐of‐life questionnaire (LVQOL) and measuring the outcome of low‐vision rehabilitation. Am J Ophthalmol 2000; 130: 793–802.
  • Lamoureux EL, Ferraro JG, Pallant JF et al. Are standard instruments valid for the assessment of quality of life and symptoms in glaucoma? Optom Vis Sci 2007; 84: 789–796.
  • Fenwick EK, Ong PG, Sabanayagam C et al. Assessment of the psychometric properties of the Chinese Impact of Vision Impairment questionnaire in a population‐based study: findings from the Singapore Chinese Eye Study. Qual Life Res 2016; 25: 871–880.
  • Finger RP, Fenwick E, Marella M et al. The impact of vision impairment on vision‐specific quality of life in Germany. Invest Ophthalmol Vis Sci 2011; 52: 3613–3619.
  • O'connor PM, Scarr BC, Lamoureux EL et al. Validation of a quality of life questionnaire in the Pacific Island. Ophthalmic Epidemiol 2010; 17: 378–386.
  • Gothwal VK, Reddy SP, Fathima A et al. Assessment of the impact of keratoconus on vision‐related quality of life. Invest Ophthalmol Vis Sci 2013; 54: 2902–2910.
  • Ratanasukon M, Tongsomboon J, Bhurayanontachai P et al. The impact of vision impairment (IVI) questionnaire; validation of the Thai‐version and the implementation on vision‐related quality of life in Thai rural community. PLoS One 2016; 11: e0155509.
  • Selivanova A, Fenwick E, Man R et al. Outcomes after comprehensive vision rehabilitation using vision‐related quality of life questionnaires: impact of vision impairment and National Eye Institute visual functioning questionnaire. Optom Vis Sci 2019; 96: 87–94.
  • Lamoureux EL, Pallant JF, Pesudovs K et al. The Impact of Vision Impairment Questionnaire: an evaluation of its measurement properties using Rasch analysis. Invest Ophthalmol Vis Sci 2006; 47: 4732–4741.
  • Nickels S, Schuster AK, Singer S et al. The National Eye Institute 25‐Item Visual Function Questionnaire (NEI VFQ‐25) ‐ reference data from the German population‐based Gutenberg Health Study (GHS). Health Qual Life Outcomes 2017; 15: 156.
  • Pesudovs K, Gothwal VK, Wright T et al. Remediating serious flaws in the National Eye Institute Visual Function Questionnaire. J Cataract Refract Surg 2010; 36: 718–732.
  • Marella M, Pesudovs K, Keeffe JE et al. The psychometric validity of the NEI VFQ‐25 for use in a low‐vision population. Invest Ophthalmol Vis Sci 2010; 51: 2878–2884.
  • van Nispen RM, Knol DL, Langelaan M et al. Re‐evaluating a vision‐related quality of life questionnaire with item response theory (IRT) and differential item functioning (DIF) analyses. BMC Med Res Methodol 2011; 11: 125.
  • Hernandez trillo A, Dickinson CM. The impact of visual and nonvisual factors on quality of life and adaptation in adults with visual impairment. Invest Ophthalmol Vis Sci 2012; 53: 4234–4241.
  • Massof RW, Fletcher DC. Evaluation of the NEI visual functioning questionnaire as an interval measure of visual ability in low vision. Vision Res 2001; 41: 397–413.
  • Andrich D. A rating formulation for ordered response categories. Psychometrika 1978; 43: 561–573.
  • Gothwal VK, Wright TA, Lamoureux EL et al. Rasch analysis of visual function and quality of life questionnaires. Optom Vis Sci 2009; 86: 1160–1168.
  • Mitchell J, Bradley C. Quality of life in age‐related macular degeneration: a review of the literature. Health Qual Life Outcomes 2006; 4: 97.
  • Vu HT, Keeffe JE, Mccarty CA et al. Impact of unilateral and bilateral vision loss on quality of life. Br J Ophthalmol 2005; 89: 360–363.
  • Brown JC, Goldstein JE, Chan TL et al. Characterizing functional complaints in patients seeking outpatient low‐vision services in the United States. Ophthalmology 2014; 121: 1655–1662.e1.
  • Binns AM, Bunce C, Dickinson C et al. How effective is low vision service provision? A systematic review. Surv Ophthalmol 2012; 57: 34–65.
  • Stelmack JA, Stelmack TR, Massof RW. Measuring low‐vision rehabilitation outcomes with the NEI VFQ‐25. Invest Ophthalmol Vis Sci 2002; 43: 2859–2868.
  • Hinds A, Sinclair A, Park J et al. Impact of an interdisciplinary low vision service on the quality of life of low vision patients. Br J Ophthalmol 2003; 87: 1391–1396.
  • Reeves BC, Harper RA, Russell WB. Enhanced low vision rehabilitation for people with age related macular degeneration: a randomised controlled trial. Br J Ophthalmol 2004; 88: 1443–1449.
  • Deemer AD, Massof RW, Rovner BW et al. Functional outcomes of the low vision depression prevention trial in age‐related macular degeneration. Invest Ophthalmol Vis Sci 2017; 58: 1514–1520.
  • Horowitz A. The prevalence and consequences of vision impairment in later life. Top Geriatr Rehabil 2004; 20: 185–195.
  • Macnaughton J, Latham K, Vianya‐estopa M. Rehabilitation needs and activity limitations of adults with a visual impairment entering a low vision rehabilitation service in England. Ophthalmic Physiol Opt 2019; 39: 113–126.
  • Brown GC, Brown MM, Stein JD et al. Vision‐related quality of life associated with unilateral and bilateral ocular conditions. Ophthalmology 2018; 125: 965–971.
  • Rovner BW, Casten RJ, Hegel MT et al. Low vision depression prevention trial in age‐related macular degeneration: a randomized clinical trial. Ophthalmology 2014; 121: 2204–2211.
  • Nollett CL, Bray N, Bunce C et al. High prevalence of untreated depression in patients accessing low‐vision services. Ophthalmology 2016; 123: 440–441.
  • Whitson HE, Ansah D, Whitaker D et al. Prevalence and patterns of comorbid cognitive impairment in low vision rehabilitation for macular disease. Arch Gerontol Geriatr 2010; 50: 209–212.
  • Radloff LS. The CES‐D scale: a self‐report depression scale for research in the general population. Appl Psychol Meas 1977; 1: 385–401.
  • Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361–370.
  • Ware J Jr, Kosinski M, Keller SD. A 12‐Item Short‐Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996; 34: 220–233.
  • Nasreddine ZS, Phillips NA, Bedirian V et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005; 53: 695–699.
  • Holloway E, Sturrock B, Lamoureux E et al. Delivering problem‐solving treatment in low‐vision rehabilitation: a pilot feasibility study. Rehabil Psychol 2018; 63: 349–356.
  • Choi BC, Pak AW. Multidisciplinarity, interdisciplinarity and transdisciplinarity in health research, services, education and policy: 1. Definitions, objectives, and evidence of effectiveness. Clin Invest Med 2006; 29: 351–364.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.